A lipid prodrug form of dexamethasone
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

LD003

Item No. 41278

Technical Information
Formal Name
(11β,16α)-9-fluoro-11,17-dihydroxy-16-methyl-21-[4-[(9Z,12Z)-9,12-octadecadien-1-yloxy]-1,4-dioxobutoxy]-pregna-1,4-diene-3,20-dione
CAS Number
2102449-40-9
Molecular Formula
C44H65FO8
Formula Weight
Purity
≥98%
Formulation
A 25 mg/ml solution in ethanol
Ethanol: Soluble: ≥10 mg/ml
SMILES
F[C@@]12[C@](CCC([C@@]2(C=C3)C)=CC3=O)([H])[C@@]4([H])[C@@]([C@](C(COC(CCC(OCCCCCCCC/C=C\C/C=C\CCCCC)=O)=O)=O)(O)[C@@H](C4)C)(C[C@@H]1O)C
InChi Code
InChI=1S/C44H65FO8/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-27-52-39(49)23-24-40(50)53-31-38(48)44(51)32(2)28-36-35-22-21-33-29-34(46)25-26-41(33,3)43(35,45)37(47)30-42(36,44)4/h9-10,12-13,25-26,29,32,35-37,47,51H,5-8,11,14-24,27-28,30-31H2,1-4H3/b10-9-,13-12-/t32-,35+,36+,37+,41+,42+,43+,44+/m1/s1
InChi Key
BSDBWIPACPNDCK-YVLPIOENSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Lipid Nanoparticle Resource Center for Additional Tools & Resources
    EXPLORE NOW
    Product Description

    LD003 is a lipid prodrug form of the synthetic glucocorticoid dexamethasone (Item No. 11015) that has been used in the formation of lipid nanoparticles (LNPs) for siRNA and mRNA delivery in vivo.1 LNPs containing LD003 and encapsulating cytosine-guanine-containing oligodeoxynucleotide (CpG) reduce the blood levels of Il-10, chemokine (C-X-C motif) ligand 1 (CXCL1), TNF-α, IL-1β, and IL-6 in mice. LNPs containing LD003 and encapsulating siRNA targeting mouse coagulation Factor VII (FVII) decrease injection site immune infiltration and hepatic levels of FVII in mice.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Wolfman, N.M., McPherron, A.C., Pappano, W.N., et alActivation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc. Natl. Acad. Sci. USA 100(26), 15842-15846 (2003).